Patient-derived cells in functional precision medicine of solid tumors

PMNET Forum 2024: Functional Precision MedicineПодробнее

Patient-Derived Xenografts for Cancer Therapeutics Development and Predictive ModelingПодробнее

Tumor fraction for patient selection in early phase trials: precision medicine analysisПодробнее

The Evolution of Precision Diagnostics in Advancing Treatment Strategies of Solid TumorsПодробнее

Sarcoma Patient-Derived Organoids for Precision MedicineПодробнее

Patient Derived Tumor Organoids for Precision MedicineПодробнее

Patient-derived Organoids and Omic Platforms for Implementing Ultra-precision Medicine.Подробнее

Can we use Patient-derived Xenografts to Assess New Lymphoma Therapies?Подробнее

The Evolution of Precision Diagnostics in Advancing Treatment Strategies of Solid TumorsПодробнее

Precision medicine/Molecular tumour boardПодробнее

Webinar: Computer-assisted functional precision medicine in cancerПодробнее

Cancer Genomics and Precision Medicine in the 21st Century - Lee HelmanПодробнее

Patient-Derived Organoids & Assays for Cancer ResearchПодробнее

Patient-Derived Micro-Organospheres Enable Precision Oncology - Terasaki Talk by Prof. Xiling ShenПодробнее

New Concepts in Immunotherapy for Solid TumorsПодробнее

Focus On: Cancer ModelingПодробнее

Clinical Utility of Functional Precision Medicine to Guide Treatments for Osteosarcoma PatientsПодробнее

Precision Medicine in Solid Tumor MalignanciesПодробнее